Browsing: Brain

The loss of Akira Toriyama serves as a poignant reminder of the fragility of life and the sudden impact that medical conditions like acute subdural haematoma can have. As fans around the world remember his unparalleled contribution to the manga and anime industry, it’s also an opportunity to raise awareness about this serious health issue, underscoring the importance of vigilance in head injury prevention and the urgency of seeking medical attention when needed.

In a recent public advisory, PhilHealth underscored its commitment to addressing the financial complexities associated with stroke care. The benefit packages for both ischemic and hemorrhagic strokes have undergone significant increases to better align with the actual costs incurred during treatment and recovery. Specifically, the benefit package for ischemic strokes has seen a substantial rise from P28,000 to P76,000, while the coverage for hemorrhagic strokes has been elevated from P38,000 to P80,000.

Discover comprehensive Memory Care Centers (MCCs) at Metro Manila’s top hospitals – Makati Medical Center, Cardinal Santos Medical Center, and De Los Santos Medical Center. These specialized facilities offer personalized services for Alzheimer’s and dementia patients, including neurological testing, innovative treatments, and supportive care management. Learn about the prevalence of dementia in the Philippines and the essential services provided by these MCCs to enhance the quality of life for affected individuals. Join the movement towards improved mental wellness and healthcare accessibility in the country.

In a stunning medical first, an Australian woman complaining of forgetfulness and depression was found to have a live 8-centimetre roundworm in her brain. Usually found in pythons, the discovery has put the international medical community on high alert, prompting an intensive review of zoonotic diseases — illnesses transferred from animals to humans.

A novel Alzheimer’s disease treatment drug, lecanemab, developed by Japanese pharmaceutical company Eisai and US firm Biogen, is nearing full approval in the US. Excitement is also building in Japan where the population of Alzheimer’s patients is growing and Prime Minister Fumio Kishida has prioritised dementia. The drug is undergoing an expedited review by the Japanese Pharmaceuticals and Medical Devices Agency and could potentially be approved this autumn.